Gummi, Rohit
Smith, Ross
Govindarajan, Raghav
Article History
Received: 1 May 2020
Accepted: 31 March 2021
First Online: 17 April 2021
Declarations
:
: Not applicable. This was a quality improvement project for medical student education. Approval would be unnecessary according to national regulations (Code of Federal Regulations 6 § 46.104 – Exempt Research).
: Not applicable.
: Dr. Raghav Govindarajan serves on the advisory board of Alexion Pharmaceuticals.Dr. Rohit Gummi has no competing interests to declare. Dr. Ross Smith has no competing interests to declare.